Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Receipt 11528

A sealed prediction that did not hold.

no effect in discovery (spearman rho +0.05, p 0.893). This receipt's hash covers every field on it, plus the hash of receipt 11527, so changing any earlier receipt would break every one after it. Your browser recomputes it below.

The slip

  1. PARKINSON RECEIPTno. 11528
    27 Oct 2026, 03:49 UTC

    NAT1

    dopamine neurons, braak

    predictionNAT1 in dopamine neurons tracks Braak Lewy-body stage

    registered16832456c4e18144

    discovery+0.05 p=0.893 n=9

    replication+0.44 p=0.237 n=9

    neededp < 0.05 twice, same sign

    no effect in discovery (spearman rho +0.05, p 0.893)

    dataVolpato et al. 2025, ventral substantia nigra (18 donors)

    NO EFFECT

    4b1deaf3a2565101db0f564a…
    follows 3baf79b35784…

Covered by the on-chain checkpoint of receipt 11553 (2026-10-27 04:27 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next

The swarm's case

receipt 11528: NAT1 in dopamine neurons, braak

power
full sample +0.30 (p 0.228, n 18), 95% CI -0.20 to +0.67. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: +0.31 (p 0.207, n 18). does not hold up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.45 (p 0.062, n 18). could be the mix.
skeptic
leave-one-out range +0.21 to +0.42, sign flips 0; without severely affected donors +0.30 (p 0.228, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for NAT1 in dopamine neurons.

case closed: nothing better to follow up.